Works by Arad, Ariela


Results: 13
    1
    2

    Bone marrow blast elimination by the fifth day of 7 + 3 induction is the strongest predictor of potential cure in patients with acute myeloid leukemia younger than 61 years of age: A long‐term follow‐up of a multi‐center prospective study

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 1, p. E3, doi. 10.1002/ajh.25651
    By:
    • Ofran, Yishai;
    • Hayun, Michal;
    • Leiba, Ronit;
    • Zuckerman, Tsila;
    • Horowitz, Netanel;
    • Hoffman, Ron;
    • Ringelstein, Shimrit;
    • Lavi, Noa;
    • Frisch, Avraham;
    • Henig, Israel;
    • Gatt, Moshe E.;
    • Hellmann, Ilana;
    • Arad, Ariela;
    • Bulvik, Shlomo;
    • Ram, Ron;
    • Gino‐Moor, Sharon;
    • Saban, Revital;
    • Tvito, Ariella;
    • Rowe, Jacob M.;
    • Ganzel, Chezi
    Publication type:
    Article
    3

    Prospective comparison of early bone marrow evaluation on day 5 versus day 14 of the "3+7" induction regimen for acute myeloid leukemia.

    Published in:
    American Journal of Hematology, 2015, v. 90, n. 12, p. 1159, doi. 10.1002/ajh.24207
    By:
    • Ofran, Yishai;
    • Leiba, Ronit;
    • Ganzel, Chezi;
    • Saban, Revital;
    • Gatt, Moshe;
    • Ram, Ron;
    • Arad, Ariela;
    • Bulvik, Shlomo;
    • Hellmann, Ilana;
    • Gino-Moor, Sharon;
    • Zuckerman, Tsila;
    • Hoffman, Ron;
    • Horowitz, Netanel;
    • Lavi, Noa;
    • Ringelstein, Shimrit;
    • Henig, Israel;
    • Hayun, Michal;
    • Rowe, Jacob M.
    Publication type:
    Article
    4

    Richter's transformation to diffuse large B-cell lymphoma: A retrospective study reporting clinical data, outcome, and the benefit of adding rituximab to chemotherapy, from the Israeli CLL Study Group.

    Published in:
    American Journal of Hematology, 2014, v. 89, n. 11, p. E218, doi. 10.1002/ajh.23826
    By:
    • Tadmor, Tamar;
    • Shvidel, Lev;
    • Bairey, Osnat;
    • Goldschmidt, Neta;
    • Ruchlemer, Rosa;
    • Fineman, Riva;
    • Rahimi-Levene, Naomi;
    • Herishanu, Yair;
    • Yuklea, Mona;
    • Arad, Ariela;
    • Aviv, Ariel;
    • Polliack, Aaron
    Publication type:
    Article
    5

    Predicting infections in high-risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: Aretrospective multicenter study.

    Published in:
    American Journal of Hematology, 2013, v. 88, n. 2, p. 130, doi. 10.1002/ajh.23368
    By:
    • Merkel, Drorit;
    • Filanovsky, Kalman;
    • Gafter-Gvili, Anat;
    • Vidal, Liat;
    • Aviv, Ariel;
    • Gatt, Moshe E.;
    • Silbershatz, Itay;
    • Herishanu, Yair;
    • Arad, Ariela;
    • Tadmor, Tamar;
    • Dally, Najib;
    • Nemets, Anatoly;
    • Rouvio, Ory;
    • Ronson, Aharon;
    • Herzog-Tzarfati, Katrin;
    • Akria, Luiza;
    • Braester, Andrei;
    • Hellmann, Ilana;
    • Yeganeh, Shay;
    • Nagler, Arnon
    Publication type:
    Article
    6
    7
    8

    A new risk model to predict time to first treatment in chronic lymphocytic leukemia based on heavy chain immunoparesis and summated free light chain.

    Published in:
    European Journal of Haematology, 2019, v. 103, n. 4, p. 335, doi. 10.1111/ejh.13288
    By:
    • Tadmor, Tamar;
    • Braester, Andrei;
    • Najib, Dally;
    • Aviv, Ariel;
    • Herishanu, Yair;
    • Yuklea, Mona;
    • Shvidel, Lev;
    • Rahimi‐Levene, Naomi;
    • Ruchlemer, Rosa;
    • Arad, Ariela;
    • Fogl, Claudia;
    • Henig, Clara;
    • Barak, Mira;
    • Magal, Lee;
    • Polliack, Aaron;
    • Townsend, Kelly
    Publication type:
    Article
    9

    Outcomes of second‐line treatment after fludarabine cyclophosphamide and rituximab in patients with chronic lymphocytic leukemia outside clinical trials.

    Published in:
    European Journal of Haematology, 2018, v. 101, n. 3, p. 399, doi. 10.1111/ejh.13129
    By:
    • Joffe, Erel;
    • Goldschmidt, Neta;
    • Bairey, Osnat;
    • Fineman, Riva;
    • Ruchlemer, Rosa;
    • Rahimi‐Levene, Naomi;
    • Shvidel, Lev;
    • Greenbaum, Uri;
    • Aviv, Ariel;
    • Tadmor, Tamar;
    • Braester, Andrea;
    • Arad, Ariela;
    • Polliack, Aaron;
    • Herishanu, Yair;
    • The Israeli CLL Study Group
    Publication type:
    Article
    10
    11
    12
    13